← Alle mensen

FG

Félix Guerrero-Ramos

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final anal...
Lancet (London, England) · 8 november 2025
TAR-200 plus cetrelimab versus cetrelimab monotherapy as neoadjuvant therapy in patiënten met muscle-invasive bladder...
The Lancet. Oncology · 2025-10